1 |
Milán-Rois P, Quan A, Slack FJ, Somoza Á. The Role of LncRNAs in Uveal Melanoma. Cancers (Basel) 2021;13:4041. [PMID: 34439196 DOI: 10.3390/cancers13164041] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
2 |
Chen Y, Ning J, Cao W, Wang S, Du T, Jiang J, Feng X, Zhang B. Research Progress of TXNIP as a Tumor Suppressor Gene Participating in the Metabolic Reprogramming and Oxidative Stress of Cancer Cells in Various Cancers. Front Oncol 2020;10:568574. [PMID: 33194655 DOI: 10.3389/fonc.2020.568574] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
3 |
Yang H, Yang H, Zhang W, Wang J, Sun L, Gao J, Zhao H, Wang Z, Aziz AUR. Identification of m6A-Related lncRNA to Predict the Prognosis of Patients with Hepatocellular Carcinoma. BioMed Research International 2022;2022:1-19. [DOI: 10.1155/2022/4169150] [Reference Citation Analysis]
|
4 |
Zhang X, Zhang X, Jia Q, Li H, Ma R, Yang G, Yin F, Jiang N, Yin D. LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis. BMC Cancer 2022;22:344. [PMID: 35351042 DOI: 10.1186/s12885-022-09360-3] [Reference Citation Analysis]
|
5 |
Yuan X, Dong Z, Shen S. LncRNA GACAT3: A Promising Biomarker and Therapeutic Target in Human Cancers. Front Cell Dev Biol 2022;10:785030. [DOI: 10.3389/fcell.2022.785030] [Reference Citation Analysis]
|
6 |
Yu W, Dai Y. lncRNA LOXL1-AS1 promotes liver cancer cell proliferation and migration by regulating the miR-377-3p/NFIB axis. Oncol Lett 2021;22:624. [PMID: 34267816 DOI: 10.3892/ol.2021.12885] [Reference Citation Analysis]
|
7 |
Tao M, Zhou Y, Jin Y, Pu J. Blocking lncRNA MIR155HG/miR-155-5p/-3p inhibits proliferation, invasion and migration of clear cell renal cell carcinoma. Pathol Res Pract 2020;216:152803. [PMID: 31889587 DOI: 10.1016/j.prp.2019.152803] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
8 |
Chen C, Su N, Li G, Shen Y, Duan X. Long non-coding RNA TMCC1-AS1 predicts poor prognosis and accelerates epithelial-mesenchymal transition in liver cancer. Oncol Lett 2021;22:773. [PMID: 34589152 DOI: 10.3892/ol.2021.13034] [Reference Citation Analysis]
|